Google
QNTM — QUANTUM BIOPHARMA LTD. (Healthcare >> Biotechnology)
QNTM FAQ
What is QNTM's ROE?
QUANTUM BIOPHARMA LTD. reports a Return on Equity (ROE) of -5,186.19%.
What is QNTM's dividend yield?
QUANTUM BIOPHARMA LTD. offers a dividend yield of 0.00%.
What is QNTM's Deepscope Quality Score?
Deepscope rates QNTM's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy QNTM?
Deepscope's AI Timing Score for QNTM is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does QNTM belong to?
QUANTUM BIOPHARMA LTD. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 4.00
Price
0.07
(1.78%)
Day Change
|
|
|---|
QNTM, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.00 |
| PBV / Sector |
-17.65 / 4.79
|
| Earning Per Share | -4.93 |
| PE / Sector |
N/A / 18.05
|
| PEG or PE/Growth / Sector |
N/A / 0.62
|
| Average 1M Daily Value |
3.34 M
GREAT
|
| Average 1W Daily Value |
1.08 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-12 09:43:26 |
| Symbol | QNTM |
| Name | QUANTUM BIOPHARMA LTD. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 6.40 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 25.15 / 9,010.81 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9
Phone: 833 571 1811
Website: https://www.quantumbiopharma.com
Sector: Healthcare >> Biotechnology
Description: Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
